Tuesday, September 23, 2008

Biotechnology Careers in the United States

The UN convention on Biological Diversity has defined Biotechnology as "'Biotechnology' means any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use".Biotechnology is a multidisciplinary subject. The European Federation of Biotechnology (EFB) considers biotechnology as 'the integration of natural sciences and organisms, cells, parts thereof and molecular analogues for products and services.' As we have seen from the definition of Biotechnology, it spreads over a wide spectrum of technologies. The key constituents of Biotechnology are: Chemical Engineering, Biochemistry, Genetics, Microbiology, Immunology, Molecular and cell Biology, Human, Animal and Plant Physiology. Biotech industry now has almost captured every sphere of human life. The industry segment is vast. To find the key trends of the industry and the market segment it covers, I will give a broad spectrum of applications of Biotechnology and its market segment. Bioprocess Technology: Better know as fermentation technology.



Biotechnology combines the study of biological sciences with technological advances to find solutions to important societal and scientific issues. Biotechnology is especially useful in research and development related to medicine and pharmaceuticals, agriculture, food production, forensics, wildlife conservation, and biological studies.
The field of biotechnology is the ultimate frontier of scientific and technological studies. Biotechnology can aptly be described as a subject that requires a multidisciplinary approach to innovation and development. Those in the industry study the basic elements of matter, such as tissues, cells, and even smaller components of life, to provide solutions to industrial and scientific problems.
Currently, biotechnology is a multidisciplinary domain in the United States. Therefore, diverse educational options exist in the field across the country. There is a growing need to produce skilled graduates who can cater to the career-related demands of the industry.
The key aim of biotechnology programs is to ensure core competence in the field of biotechnology. Diverse objectives include preparing researchers, managers, technicians, and other professionals to fuel the surge in the biotechnology industry. Biotechnology graduates may also elect to pursue higher qualifications in such fields as biophysical science, mechanical engineering, and computing.
Educational programs range from certificate and bachelor's degree programs to master's and doctoral degree programs. To cater to the managerial and leadership needs of the biotechnology industry, some universities offer dual degree programs as well. These programs include managerial preparation along with biotechnology training.
Presently, the biotechnology industry offers a variety of career options for biophysical science, agricultural scientists, general practitioners, forensic scientists, laboratory technologists, and veterinarians.
More and more career options are opening up in the industry. Biotechnology graduates with some experience can expect to find employment as bioinformaticians, consultants, and industry researchers. Biotechnology graduates with management skills can expect to find employment as biotechnology consultants and biotechnology directors.
Although biotechnology has conventionally retained its identity as an academic domain, there is a growing demand for highly educated professionals in biotechnology businesses. Presently, there are around 1,500 biotechnology companies in the United States. Together, their business totals more than $40 billion.
There is a growing need to meet the growing demand for biotechnology professionals and qualified graduates produced by universities in the United States. However, most biotechnology professionals attuned to academic lifestyles are finding the change drastic due to industry expectations with regard to returns on investment.
Businesses cannot afford to lose good scientists with sound academic and research credentials. What is required is simply adaptation to the business aspects of biotechnology. Therefore, even if biotechnology scientists do not display entrepreneurial desires, a series of short-term training programs can help fill the gap between academics and business.

Monday, September 22, 2008

Private-Public Sector Partnership Necessary in Biotechnology Research

There are very interesting developments in the field of agricultural biotechnology currently taking place in India.The Maharashtra Hybrid Seed Company (Mahyco) has offered to transfer the technology and basic breeding material of Bt Brinjal, a low calorie vegetable widely grown in India, to two public sector institutions; The Tamil Nadu Agricultural University, Coimbatore (TNAU) and the University of Agricultural Sciences, Dharwad (UASD).The public sector institutions will not pay any royalty as long as they don’t commercialize the genetically modified Brinjal. This is a very unusual, but highly significant gesture.Private seed companies, especially in the field of biotechnology, are not known to freely share innovational information with public organizations. They keep such information under a lock and key for fear of patent infringement. While this is understandable, it has fueled animosity and suspicions among scientists working in public institutions, especially in developing countries.Obviously, no company would be willing to invest billions of dollars to develop new seed varieties only for an armchair scientist to copy cat them. But the need to safeguard proprietary information shouldn’t override the desire for seed companies to partner with public institutions. Doing so will deny the anti-biotech crowd a chance to characterize biotech companies as selfish and secretive.Mahyco has set a good example that all biotechnology seed companies should follow. Biotech companies stand to benefit if they open their doors wider to public institutions. This is especially critical in Africa where genetically modified crops are yet to make major inroads.It can’t be gainsaid that there is already such partnership going on in Africa. In Kenya, for example, the Kenya Agricultural Research Institute (KARI) is working closely with biotech seed companies in the development of genetically modified maize resistant to stem borers. But more such partnership is needed to accelerate the adoption of genetically modified crops in developing countries.


The Future Of Biotechnology Jobs In The UK

Science and technology have become fused in many ways throughout the United Kingdom. Medical technology has advanced immeasurably, applying electronics and computing to assist in many forms of diagnostic equipment and tests. Pharmaceutical companies facilitate their ability to compete in a difficult global marketplace by investing in mobile computers and PDAs for personnel in order to enable them to carry full information and present their product lines. Chemical engineering departments throughout the UK are utilising highly advanced equipment, often linked to computer technology, in the course of their work. One result of this growth in the application of technology , in particular for medical science, is the creation of a vibrant biotechnology job market in the UK.Biotechnology may be regarded as the combination of technology and living organisms in the interest of scientific endeavour and advancement. The efforts mentioned above are only a few examples of the jobs available to graduates interested in this burgeoning field. The biotechnology job market, however, is a difficult one to assess for young professionals since it is a relatively new field in the private sector. However, an astute biotechnology engineer or consultant may appraise job prospects by looking at three key branches of this scientific field.Red biotechnological endeavours are those that involve the medical profession. These scientific efforts have produced amazing results, including advancement in the use of living organisms to create antibodies and the generation of new vaccines. The medical profession is grappling with the ethics of certain aspects of biotechnology, including manipulation of genes by powerful computer-aided operations. However, professionals with a medical background and an understanding of information technology will be able to take advantage of the fact that red biotechnology will expand further in the future.Many manufacturers and industrial facilities are beginning to utilise gray biotechnology in order to cut overhead costs and improve environmental protection. Gray biotechnological professionals, like chemical and production engineers, look to the enhanced use of living organisms to make processes easier and more acceptable. Facilities that treat sewage and water, for example, can use certain bacteria in the filtration process to eliminate harmful organisms before they reach the public. These positions are perhaps the most prevalent in the United Kingdom and biotech professionals interested in this field may benefit accordingly.Green biotechnology, which provides assistance to farms and agricultural businesses, is a specific aspect of this scientific field. Biotechnology used on the farm includes the creation of plants that can endure a variety of meteorological conditions and the use of treatment options on products to be sold for public consumption. Agricultural jobs are at a premium in the United Kingdom but biotech professionals with a background in agriculture are usually assured of long term career success. Leading stores and other food providers rely on green biotechnology for the consistency of many of their food products.Article Source: U Publish Articles by Stephen Trigg

Saturday, September 20, 2008

Introduction of biotechnology

The UN convention on Biological Diversity has defined Biotechnology as "'Biotechnology' means any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use".Biotechnology is a multidisciplinary subject. The European Federation of Biotechnology (EFB) considers biotechnology as 'the integration of natural sciences and organisms, cells, parts thereof and molecular analogues for products and services.' As we have seen from the definition of Biotechnology, it spreads over a wide spectrum of technologies. The key constituents of Biotechnology are: Chemical Engineering, Biochemistry, Genetics, Microbiology, Immunology, Molecular and cell Biology, Human, Animal and Plant Physiology. Biotech industry now has almost captured every sphere of human life. The industry segment is vast. To find the key trends of the industry and the market segment it covers, I will give a broad spectrum of applications of Biotechnology and its market segment. Bioprocess Technology: Better know as fermentation technology. Traditional forms of bioprocess technology related to food and beverages, but new products are increasingly being derived from microbial and mammalian fermentations. Bioprocess technology is increasingly using cells derived from higher plants and animals to produce many important products, foods and beverages. Enzyme Technology: Food production and preservation, improvement of the environment, and other medical sectors. Waste Technology: Biotechnologyis used to produce Single cell protein (SCP) from organic wastes. SCP is used as protein supplement for animals and human. The waste technology is also supplementary to Environmental and Energy Technology, giving rapid progress in these two segments. Environmental Technology; Waste water and sewerage treatment, Landfill technologies, composting, bioremediation, Detection and monitoring pollutants, microbes and geological environment, environmental sustainability and clean technology. Resources Technology: The use of biomass as a source of energy supplements the use of fossil fuel. Plant, animal, agriculture: Plant Biotechnology, Improved varieties of agricultural products using tissue culture, improved resistance to specific herbicides, improved resistance to insects, pests and microbial diseases, improved post harvest characteristics, production of high values oil products, forest biotechnology, biological control, animal biotechnology, genetic engineering for transgenic animals, genetically engineered hormones and vaccines, animal organs for human patients, diagnostic in agriculture, genetically developed seeds, Health care: New products based on biotechnology are appearing almost daily in the market place, These includes therapeutic products, pre-natal diagnosis of genetic diseases, vaccines, immunodiagnostic and DNA probe of disease identification, and genetic therapy. The use of Antibiotics, Vaccines and monoclonal antibodies, Biopharmaceuticals, insulin, somatostain, interferons, lympokines, Gene therapy are giving new impetus to fight the diseases like AIDS, cancer etc. This is one of the most important segments of market, where Biotechnology is going to take over completely. Crime detection and identity verification: This segment deals with use of genetics for crime detection. Metal recovery; Genetically designed microbes are used in the process of extracting oil from ground and metals from factory waste. Today Biotech industry has penetrated in every sphere of human life. While looking into the market segment and key trend in Biotech industry, we need to consider another factor of the use of Biotechnology, which is gaining momentum over the years, i.e. ethical questions arising out of use of Biotechnology. There is a group of population, who are against use of genetically developed fruits and vegetables. There is going to be an influence of this sentiment in deriving the market segment of Biotech industry. However the positive use of Biotechnology too great, and we can look forward for new additions of Products and Services using Biotechnology.

Saturday, September 13, 2008

The Future Of Biotechnology Jobs In The UK

Science and technology have become fused in many ways throughout the United Kingdom. Medical technology has advanced immeasurably, applying electronics and computing to assist in many forms of diagnostic equipment and tests. Pharmaceutical companies facilitate their ability to compete in a difficult global marketplace by investing in mobile computers and PDAs for personnel in order to enable them to carry full information and present their product lines. Chemical engineering departments throughout the UK are utilising highly advanced equipment, often linked to computer technology, in the course of their work. One result of this growth in the application of technology , in particular for medical science, is the creation of a vibrant biotechnology job market in the UK.Biotechnology may be regarded as the combination of technology and living organisms in the interest of scientific endeavour and advancement. The efforts mentioned above are only a few examples of the jobs available to graduates interested in this burgeoning field. The biotechnology job market, however, is a difficult one to assess for young professionals since it is a relatively new field in the private sector. However, an astute biotechnology engineer or consultant may appraise job prospects by looking at three key branches of this scientific field.Red biotechnological endeavours are those that involve the medical profession. These scientific efforts have produced amazing results, including advancement in the use of living organisms to create antibodies and the generation of new vaccines. The medical profession is grappling with the ethics of certain aspects of biotechnology, including manipulation of genes by powerful computer-aided operations. However, professionals with a medical background and an understanding of information technology will be able to take advantage of the fact that red biotechnology will expand further in the future.Many manufacturers and industrial facilities are beginning to utilise gray biotechnology in order to cut overhead costs and improve environmental protection. Gray biotechnological professionals, like chemical and production engineers, look to the enhanced use of living organisms to make processes easier and more acceptable. Facilities that treat sewage and water, for example, can use certain bacteria in the filtration process to eliminate harmful organisms before they reach the public. These positions are perhaps the most prevalent in the United Kingdom and biotech professionals interested in this field may benefit accordingly.Green biotechnology, which provides assistance to farms and agricultural businesses, is a specific aspect of this scientific field. Biotechnology used on the farm includes the creation of plants that can endure a variety of meteorological conditions and the use of treatment options on products to be sold for public consumption. Agricultural jobs are at a premium in the United Kingdom but biotech professionals with a background in agriculture are usually assured of long term career success. Leading stores and other food providers rely on green biotechnology for the consistency of many of their food products.Article Source: U Publish Articles by Stephen Trigg

Saturday, September 6, 2008

Farm Subsidies Can Threaten Biotechnology In African Countries

There is growing consensus that modern biotechnology holds the key to sustainable development. This is, especially, in the light of the fact that the world's population is fast growing without corresponding land expansion. Modern biotechnology is considered cost effective and therefore very applicable to poor resource farming. Scientific evidence exist that associate genetically modified crops with high yields. This explains why Sub-Saharan Africa, long ravaged by drought and famine is being encouraged to embrace modern biotechnology.

Modern biotechnology is already dominant in the US, Canada, Spain, Mexico, China, Argentina, and Brazil. These countries not only produce enough for their domestic consumption but also for export. Perhaps, this is the most significant aspect of GM cultivation. For without ready market surplus yields would go to waste. I raise this issue because the current trade imbalance threatens to imperil North-South technology transfer. This is especially critical in Africa, which for many years has been struggling to penetrate oversees markets with little success.

Let me illustrate this point. Currently, the US and Europe are involved in a bitter trade war with four West African countries - Burkina Faso, Benin, Chad and Mali, over subsidies they offer their cotton farmers. The four West African countries, popularly known as C4 attribute low cotton prices, which are seriously strangling their farmers, on these subsidies. Subsidies are meant to ensure that farmers always get value for their farm investments. They don't have to worry about price fluctuations for they are guaranteed of compensation by their governments.

The current arrangement where the US and Europe heavily subsidize their cotton farmers heavily disadvantages their counterparts poor countries whose governments cannot afford subsidies! Their cotton ends up fetching little money, effectively making its farming unsustainable. The once white gold of West Africa is about to turn to dust. This is unacceptable for it means bankrupting the economies of these already poor countries. Twelve out of the 15 Economic Commission for West African States (Ecowas) states are considered least developed. Don't rich countries feel that they have a contribution to make to extricate these countries from the yokes of poverty?

In Benin and Burkina Faso, cotton accounts for about 40 per cent of merchandise export earnings, while in Mali and Chad it accounts for 30 per cent. Cotton, is, therefore the back bone of the economies of these countries.

It is instructive to note that direct losses to West Africa as a result of US and EU subsidies are estimated at $250 million per annum. The US, alone, in the 2001-2002 season subsidized its cotton farmers to the tune of $2.3 billion. The economic damage wrought on these countries by subsidies is unfathomable. Action is urgently needed and the US and Europe must come to their rescue.

These West African countries have now petitioned the World Trade Organization (WTO) to correct this trade imbalance. Sadly, the US and Europe are busy digging their heels to frustrate them. Their action is ill-advised and in bad faith.

During the September 2003 WTO Cancun ministerial conference, the US government proposed that the West African countries diversify from cotton growing. Why should these countries diversify from cotton farming? This defeats the very spirit of modern biotechnology which, among other benefits, guarantee farmers high yields.

As one of the strategy to help cotton farmers improve their cotton farming, the US, through the powerful International Cotton Advisory Committee and United States Agency for International Development (Usaid) is offering to share biotechnology breakthroughs with them. This transfer of technology, as a matter of fact, will lead to high yields. Where are they expected to take their surplus cotton if the global market for this product remains tilted in favor of the US and Europe?

There is general goodwill on the part of African countries to embrace modern biotechnology. Some West African countries, notably Mali and Burkina Faso, are already experimenting on Bacillus thurigiensis (Bt) Cotton in the hope of improving their cotton farming. The best way for the US and Europe to encourage poor countries to embrace modern biotechnology is to guarantee them ready market for their farm produce. Removing farm subsidies is the first step towards achieving this goal.

Thursday, September 4, 2008

The benefits of biotechnology investing

an has been looking since ages to find newer cures and bring about a marked advancement in the filed of medical applications. In the last few years, biotechnology has contributed significantly towards this field.

There have been significant developments in biotechnology making it one of the most lucrative investment options. Yes, biotechnology investing is considered to be the future by many investment experts.

Most venture capitalists today are looking at biotechnology companies in a different light. The opportunities for investors to generate impressive revenue growth are one of the prime reasons why this has happened.

Also the trend to spend till we get the best in health care is another reason. Man does not like to compromise when it comes to good health and biotechnology has been one of the chief gainers of this principle.

Why Biotech?

There are many small biotech companies who are waiting for that golden opportunity. Some of these companies have displayed their flair and skill in just a few years of their existence.

With the right investors these companies can work wonders. Who knows, the drug for Alzheimer’s or cancer might just be underway in some of these companies.

From a business point of view, such a drug can be the single factor that will power you from rags to riches.

But biotechnology investing is not that easy. It is a task that requires a set of special skills so that you can spot the best company instantly.

Finding the right company to invest

There are many companies who will make the job of biotechnology investing easier for you, the investor.

These companies have the scientific, medical and financial experts who will analyze most biotech companies giving you comprehensive advice on which company to invest in.

With just a clinical trial, these analysts will help you determine what future prospects the company holds.

For more Information on bio technology investing
Visit http://www.ibfconferences.com .

Wednesday, September 3, 2008

Biotechnology - Career in Research and Development:

Taking up a job in biotechnology means involving oneself in the development of new products and processes for the good of mankind and quality of life. Before one seriously considers a career in biotechnology, it is imperative to have extensive knowledge in biology, chemistry, and other life sciences.

Biotechnology also has a deep impact on other areas such as human health careers which involves detecting and treating hereditary diseases, cancer, heart disease, AIDS, etc; in Veterinary Medicine, Animal Science, and Livestock Production; and in Agriculture and Plant Science.

A biotechnology company has a number of divisions, each performing different tasks and functions.

Career in Research and Development:

Like any other company, a biotechnology company also needs a qualified team of researchers to represent its future. While some researches may focus on a specific application, some may be carried out for acquiring new knowledge which may not need immediate application. Researchers may also work in academic environments such as universities or within the premises of the company setup. The most important thing is that research and product development form the foundation and basis of any biotechnological setup.

Career in Production and quality control:

People who have extensive knowledge of engineering or industrial-manufacturing technology are required by biotechnological firms in production and manufacturing. In order to make sure the finished products meet specifications, a group or team of quality assurance look after the production process, research and development. This group of experts belongs to the quality control division.

Career in Management:

Biotechnology companies need managers who can supervise the working of the company such as Research and Development, Production, and Quality Control. These people are often Ph.D. level scientists who have worked their way up through special achievements or accomplishments. They may also have business training and experience sometimes.

Career in Sales and Marketing:

Market researchers analyze, assess and estimate the need for a specific product and it would sell. They advertise and promote, and try to find new markets for products already being sold. Salespersons deal directly with consumers by selling, getting feedbacks etc, and are the most visible representatives of the biotechnology company.

Career in Regulatory Affairs

Since all biotechnology companies, especially agricultural and pharmaceutical, are regulated by federal and state agencies such as FDA, EPA, and USDA regarding the safety, ethics etc of manufacturing and products, they need a team of experts and specialists to make sure the company follows all regulations laid down by these agencies.

Career in Legal Affairs:

Any invention or discovery is not safe from copyright infringement without the proper patent. Since biotechnology companies and firms are continually engaged in the search for newer and better products, they need people specializing in law to prepare patent application, or keep track of patent laws.

Career in Public Relations, Communications, and Training:

Biotechnology companies must be able to relay information to the public or other agencies in a language they will understand because biotechnology involves the use of technical terms much of the time. They must also be able to convince others on the credibility and usefulness of their products. As the company grows bigger, the scope of its recruitment also grows along with it. This would imply the need for more training and staff development, and hence more trainers.

Author:
Andrew Green

Tuesday, September 2, 2008

Australian researcher wants more young people to study science

Australian researcher wants
more young people to study science
By James Njoroge
There�s

this article about Professor Wynne Jones, of Harper Adams University College
in Australia, urging young people to study science. Actually, this is not the
main theme of the article: It�s about the controversy surrounding genetically
modified

GM foods, and how it can be solved through public education.
Jones sneaks in the idea of
egging on young people to study science and technology so that that they can
lead this campaign, a theory I�ve not heard since I started blogging about
agricultural biotechnology. And I�ve not come across a study that shows young
scientists can execute public awareness campaigns about agricultural
biotechnology, or any other controversial scientific innovations, than their
older counterparts.
In this article, Jones
rightly argues the world would be a better place if more young people study
science and technology. Apart from gaining scientific knowledge for their career
and professional development, Jones further argues, these young scientists - as
a service to the community - would be invaluable asset in educating the public
about new scientific innovation.
Jones says the debate about
genetically modified foods can greatly benefit from young scientists. They�ve
the energy and tact to convince a wary public that modern agricultural
biotechnology has great potential.
�It�s up to us as
educationalists and scientists to inform the public and have a debate based on
fact and not heated emotions,� Says Jones referring to the confusion surrounding
genetically modified organisms (GMOs).
Jones can�t be further from
right on this issue. More education and awareness about

GMOs is needed. As I�ve repeatedly argued on this blog, the public has been
denied education about GMOs. And to blame for this situation are scientists who
always shy away from confronting those who try to distort their work. As Jones
puts it, it�s high time they fill up the plate.
James
Njoroge authors the

GMO Africa blog which enhances public understanding of
agricultural biotechnology. More on the Web at

Sunday, August 31, 2008

Europe Must Listen to Mandelson on GM Food

The European Union (EU) Trade Commissioner, Peter Mandelson, last week, and for the umpteenth time, appealed to European countries to adopt an open approach to agricultural biotechnology and genetically modified (GM) food.

In a speech during the European Biotechnology Open Day in Brussels, Belgium, Mr. Mandelson counseled Europe to embrace biotechnology that “… prioritizes strict science-based health and safety testing but which recognizes that safe biotechnology has a crucial role to play in agriculture and agricultural trade both in Europe and the developing world.”

He warned Europe against stonewalling on biotechnology, and especially genetically modified food.. “We must be under no illusion that Europe’s interests are served by being outside a global market that is steadily working its way through the issues raised by GM food. They are not!” Said Mr. Mandelson.

It’s not the first time Mr. Mandelson is asking European countries to discard their negative and misplaced perceptions about agricultural biotechnology and GM foods. On several occasions, Mr. Mandelson has questioned Europe’s recalcitrant stand on GM foods.

Soon after the World Trade Organization (WTO) issued a ruling that found the EU in violation of international trade rules for placing a moratorium (since lifted) on GM foods in 2005, Mr. Mandelson called for a civil debate on GMOs. He argued that the debate about the pros of genetically modified foods must be anchored on verifiable scientific facts.

In his last week’s speech, Mr. Mandelson moaned that the current GMOs debate disregard scientific facts, and, instead, dwells on generalizations. Nobody can dispute Mr. Mandelson’s assertion that raw politics is what drives the GMOs debate. We have anti-biotechnology activists saying this and that about GM food without adducing scientific evidence. These people see nothing positive in food biotechnology, and this is what has polarized the debate on GM food.

Despite Mr. Mandelson’s protestations, Europe’s stance on GM food, unfortunately, hasn’t changed, which prompts me to ask, “Do European countries believe in their own institutions?” I don’t think they do. If they did, they would have listened to Mr. Mandelson. How comes Mr. Mandelson acknowledges genetic engineering pros, while countries that he represents don’t?

Mr. Mandelson’s views on GM food are not his own. They reflect the official position of the EU, to which countries that oppose them belong. Why they, deliberately, refuse to heed Mr. Mandelson’s advice is really intriguing.

Poor countries excuse themselves from crop genetic engineering on pretext that that they lack mechanisms to test the safety of GM food. The EU, as Mr. Mandelson puts it in his Brussels speech, has such mechanisms, but it has refused to use them, and instead relied on anti-biotechnology advocacy groups such as the Greenpeace and Friends of the Earth to shape policy.

As I have repeatedly stated in this blog, the EU’s policy on GM food hurts not only European countries, but also developing countries. These countries would not dare practice biotech agriculture for fear of losing European markets for their agricultural products. By default, the EU is preventing the developing world to plant GM crops. This is unacceptable. Crop genetic engineering is a reality that won’t disappear just because a scare-monger somewhere is saying this and that about GM food.

Saturday, August 30, 2008

A Robust Seed and Biotechnology Program Needed in Africa

In a recent meeting, African Union (AU) Ministers of Agriculture endorsed the development of the African Seed and Biotechnology Program (ASPB). The ministers, meeting in Libreville, Gabon, seemed to acknowledge that Africa is in short supply of quality seeds, and that’s why its agricultural sector remains in the doldrums. This situation is self-inflicted, and has more to do with the politicization of seed technologies. It's encouraging that the AU is making deliberate efforts to promote biotechnology in the continent.

Africa is financially constrained to develop high-yielding seeds. It doesn’t have the technological know-how. Worse, scientists who could have been the force behind new seeds development have fled to developed countries to seek greener pastures.

The reality, then, is that developed countries are the sole sources of high-yielding seeds. Through genetic modification, biotechnology companies in these countries have managed to develop drought and pesticide resistant seeds whose returns have been great. The bounty harvests farmers in the U.S. Canada, and developing countries such as China and India realize from biotech seeds only attest to their productivity.

Biotech companies have always sought to correct this situation, by extending these benefits to farmers in developing countries. But their efforts have been met with resistance. A cabal of anti-technology activists continues to spread lies that multinational biotech companies seek to colonize the seed industry.

I am wondering if AU Agriculture Ministers addressed this issue during their Libreville meeting. If they want the ASPB program to succeed, they must start viewing multinational biotech companies as agents of development. They must extend a hand of friendship to them knowing very well it’s their farmers who stand to benefit.

I note that Malawi and Zambia were represented in this meeting. These two are, perhaps, are the most vocal critics of genetically modified foods in the African continent. How will they be good overseers of the envisioned seed and biotechnology program with their current hostile policies towards genetically modified foods?

ASPB is a good idea, but its architects must demonstrate by words and deeds that they’re genuinely for it. They could do so by initiating agricultural biotechnology sensitization programs in their respective countries. This way farmers will be aware they’re dealing with a progressive technology.

Landing the Perfect Biotechnology Job

The euphoria of graduation day has worn off. You have done it – finished up that degree, made your family proud, and now it is time to strike out on your own. Your love of the field led you to seek and earn a degree in biotechnology, but how do you go about finding a job in such a field? It isn’t as hard as you might think. You can find a job in biotechnology, or any field, with a little bit of dedication and prep work.

Biotechnology – or the use of technology to modify organic (living) material – is a vast field that has been around for years. While there are several subcategories of the field, the main ones are agriculture, industry, medicine, and bioinformatics. The vastness of the field works in your favor, as there are many options for employment. You could end up working in a brewery or winery to make that perfect drink, or working in the field to minimize the damage an oil spill or other chemical spill might have on wildlife, or even working in a lab on pest control, genetics, or pharmaceuticals. All of it is biotechnology.

The vast array of options aside, how exactly do you go about securing that all-important job? In addition to a biology or biotech degree, you will need a strong resume. Post it to every online job bank you can. Really good ones for biotech jobs are www.Biospace.com, www.cleanroomjobs.net and www.Biotechnologyjobs.com. Posting your resume allows employers to find you. When they call, the initial screening is already complete, and you’ll know you passed.

Search the online job bank databases as well. Don’t just stick to popular sites like Monster, CareerBuilder, and HotJobs. Try looking at databases dedicated to the biotech job scene. In addition to the above two, check out www.ihirebiotechnology.com and www.sciencejobs.com. Many universities offer free job placement services and career counseling – take advantage of that while you can. They may have connections or knowledge of listings for entry level jobs that are not posted elsewhere.

Another approach to landing that job is to attend job fairs hosted by companies in the biotechnology industry. You can find out about these by reading newspaper classifieds, visiting the human resources pages of the companies you are interested in, and by checking announcements posted in job forums. Make your social networking time pay off!

Lastly, don’t be afraid to use word of mouth when it comes to successful job searching. Sometimes, the adage, “It’s not what you know, its who you know” proves true. Ask friends, family, or someone “in the know” if they are aware of any jobs that would be right for you. Sometimes, your best tools for job searching are your mouth and ears. Use them wisely.

As vast as the field of biotechnology is, you are bound to find at least an entry level position in a reasonable amount of time. With patience and persistence, the perfect biotechnology job will come your way. Use the resources that are available to you, and watch your career take off.

Friday, August 29, 2008

The Connection Between Best Acne Treatments and Technology

Some of the best acne treatments offered today are based or developed through high technology and scientific innovations. The emergence of high tech medical devices and instruments has changed the way medical and health-related concerns are addressed by specialists and the public in general.

One of the areas of medicine that has benefited from technology is dermatology. The emergence of biotechnology, LEDs and laser has allowed scientists to develop some of the best acne treatments that man has ever seen. Arguably, technology is the best thing that has ever happened to medicine.

The discovery of LEDs, lasers and fluorescent lighting has led to the development of the use of visible light in treating acne, a process better known as phototherapy. This method of treatment has been shown to reduce 64 percent of acne lesions when used twice a week. The method apparently works better when combined with red visible light. The combination has been found to reduce lesions by 76 percent after three months of daily use.

Laser surgery is already used in reducing scars caused by acne and researchers are now focusing on whether the same method can be employed to prevent the actual formation of acne. Laser technology is currently being developed to burn away follicle sac and sebaceous gland and induce the formation of oxygen in the bacteria to kill them. As of 2005, these scenarios remain in the research stage and are not yet established as definite treatment methods.

Another area of high technology that presents a lot of promise for treating acne is biotechnology, particularly the fields tied with genetics. Since acne is believed to be linked with heredity, whole-genome DNA sequencing has been the focus of some research efforts. The aim is to understand the body mechanisms involve in acne formation. The use of gene therapy to alter the DNA of the skin also seems to be a not too far possibility.

Technology has provided us with some of the best acne treatments ever known to man. More possibilities are still waiting to be discovered and 21st century science is on the verge of making all these possibilities a reality.

Kerwin Chang writes for http://www.acnestuff.net where you can find out more about acne and other skin care topics.

Thursday, August 28, 2008

Biotechnology – Its Latest Trends And Techniques

One of the fastest growing research areas in the world is Biotechnology as we know it. The basic idea behind biotechnology is using living things to create products rather than the other way around. We often times see that the living organisms are nothing more than parts of DNA structure or code which will help the researcher to develop the idea that he or she has working. The organisms do what the research does not have the power to do, hence their small size. The organisms are used to perform the tasks that are impossible for humans and can only be accomplished by the tiny particles that are working inside everything we see and touch on a daily basis.

The trends in biotechnology are inviting to a good many areas of the world. The industrial sector is extremely interested in biotechnology as they need new ways to develop products without the use of humans. This is generally because the process that is used to make the products can be overtly dangerous to people and the job needs to be performed by something that will not be harmed. This is where biotechnology fits into the process. The particles that are used will set to work doing the only task they know how. This in turn helps the company as they have developed the way to make sure that none of their employees were harmed and the job was done correctly without the intervention of humans to the methods. This is popularly shown with the new one way reactor that is being installed with many of the larger industry areas. Rather than the power having to move back and fourth it comes out and stays out while the reactor continues to make more. This would not be possible if it were not for the biotechnology research that has been done in this area.

The other most important area that biotechnology is present in is the medical or red sector. Using the techniques that biotechnology employs researchers believe that they are very close to having a system that will diagnose and attack tumors in the body without surgery. This would all be done by way of an injection that would contain the biotechnology particles and organisms that are specifically made to attack and diagnose the tumor as it is found in the body. This is very good news for the many cancer patients of the world. When you operate on a cancer patient you run the risk of the disease spreading or missing some of the cancerous material that is contained therein. This will be completely unnecessary if the use of biotechnology reaches a point where it will do the job that it is made to do.

Biotechnology is changing the way that the world is created around us and is working to help cure some of the most horrible diseases that are currently known to man.

Tuesday, August 26, 2008

Biologist aims to create life from scratch

ROCKVILLE, Md. Biologist J. Craig Venter once raced the United States government to complete the decoding of the human genome. Now career studying the code of life, Dr. Venter has a new goal which is.. life itself.

Along with two other veterans, Dr. Venter hopes to become the first to construct a made to order bacterium. Normally new life is created by reproduction, with each generation passing it's genes on to the next. But Dr. Venter aims to bypass that process by creating a complete set of genes, or genome of a single-cell bacterium in his laboratory. This man made genome would be installed inside a bacterium whose own genes have been carefully removed.

Antonio's article goes on to say, by artificially creating such a life form Dr. Venter's researchers hope they may come closer to understanding what life is and how scientists can manipulate it for the benefit of mankind. New artificial species could possibly open avenues for the industrial production of drugs, chemicals or even clean energy.

"This is the next big step we have all been talking about. We're moving from being able to read the genetic code to actually writing it," Dr. Venter says, with a huge smile.

Spurring on Dr. Venter's latest ambition is a $12 million grant from the U.S. Department of Energy. Also an additional $30 million being raised by Dr. Venter and his business partners from various sources such as several wealthy private investors will bankroll a new company, Synthetic Genomics Inc. The company will assist funding the research program at Dr. Venter's non-profit research institute and own the rights to any intellectual property the program creates.

A number of researchers are speeding toward similar goals. Teams at Harvard University and teams in Japan are attempting to make new versions of common E. coli bacteria with totally synthetic genes. On many campuses "synthetic biology" is the latest buzzword. Students are now being taught to program the DNA of bacteria as if it were a piece of software running a computer.

Scientists have known for approximately 30 years how to add genes to a bacterium. That is the basic discovery behind the biotechnology industry. For example, insulin for diabetics is being manufactured by splicing an insulin making gene into a microbe. Dr Venter's plan is to take this technology to the next level - to manufacture and combign all the genes necessary for a bacterium to survive. For now, he will still need to utilize the shell of a living microbe, with its genome removed to complete the creation of what he calls the first "human-made species."

The most fundamental hurdle Dr. Venter faces is getting his concoction to work. It's possible that his team could create the genome, place it inside the bacterial cell, and find that nothing happens - analogous to installing a new operating system in a computer and having it crash.

If the cell does "boot up," Dr. Venter believes the creation will have "10,000 applications," providing a template onto which scientists could add and test new functions. He imagines an organism perfected to make clean hydrogen energy from sunlight. Another would chew up cellulose, the raw material of plants, and spit out ethanol that could be used as car fuel which will have massive beneficial effects on the environment and as well as to people.

Sunday, August 24, 2008

Tony Blair on Genetically Modified Food Debate

his week, I want to idolize British Prime Minister, Tony Blair, because of remarks he made last week on genetically modified foods.

Addressing a group of scientists last week, Mr. Blair suggested that opponents of genetically modified foods aren’t “rational” when debating this issue.

"Government must show leadership and courage in standing up for science and rejecting an irrational public debate around it [GM food]," said Mr. Blair, referring to “those who have distorted facts to oppose developments such as GM foods.”

Mr. Blair, expectedly, did receive flaks for these remarks. Some challenged him to state if he was openly criticizing Prince Charles, who has openly opposed genetically modified foods [I must, hereby, mention that Prince Charles is wrong to use the privileges of the British throne to make statements that can’t be scientifically substantiated about genetically modified foods].

Others insinuated that it was payback time to multinational biotechnology companies, for millions of dollars donated to the Labor Party.

I found this quite amusing because of instead of addressing real issues, Mr. Blair’s critics decided to dwell on side issues. This, needless to say, has been the hallmark of the debate about genetically modified foods.

Opponents of genetically modified foods dare not attack the science behind genetically modified food because they have no case to make against it. Instead, they go for fringe issues with the aim of confusing the public.

Mr. Blair is right in urging the public to “discuss technological innovations in a more scientifically literate fashion.” Those who genuinely care about food safety should support and not criticize him. Mr. Blair evidently means well for the world.

How else can the world determine the safety of genetically modified foods other than subjecting them to thorough laboratory investigations? This is the premise of Mr. Blair’s argument.

Genetically modified foods have been subjected to rigorous examination by various scientific bodies. The British Royal Society of Science has produced numerous reports showing that genetically modified foods can be beneficial to humans and the environment.

Various United Nations Agencies, notably the World Health Organization (WHO) and Food and Agriculture Organization (FAO) have also published similar reports.

Perhaps Mr. Blair should use his political leverage to prevail upon other European countries to change their attitude towards genetically modified foods. Currently, Europe maintains the most draconian and restrictive laws on genetically modified food. These laws aren’t informed by science, but by populist sentiments

Thursday, July 24, 2008

A Bird's-Eye View of Biotech Jobs

The term "biotech," short for "biotechnology," refers to the application and manipulation of biological resources to develop products and processes that fulfill industrial and other human objectives. While popular imagination tends to latch onto controversial fields of biotechnological research like DNA typing, cloning, and stem cell research, the fact is that biotechnology has commonplace applications ranging from bread production to wastewater recycling that influence our daily lives. The consequence of this wide reach of biotechnology is that the number biotech jobs continues to grow faster than the numbers of jobs in other sectors.

The Divisions of Biotech

A great number of industries are directly influenced by biotechnology, and it would be difficult to mention all of them in a short article. However, to provide a broader perspective, jobs in biotechnology can be grouped into three functional categories:
Research and development: Considered by some to be the most prestigious division of biotech research and development (R&D) creates the frontiers of biotechnology and sets the paradigms that influence both humanity and the biotech job market. The three major divisions of biotechnological R&D are research for discoveries, veterinary sciences, and bioinformatics. Jobs in this sector are usually reserved for life scientists.
Clinical research and safety: Once a functional process or product is developed by R&D, the necessity to establish trials to determine the impact of the product or process on public health and safety emerges. Biotechnologists working in this field ensure the safety of biotechnological products and processes.
Compliance: Issues of compliance with respect to biotechnological products and processes—in terms of both quality and standards and rules established by the state—create openings for biotechnologists.
Openings for biotechnologists are also available in the following specific areas and functional fields:

Medicine and Pharmaceuticals

In this broad field, the following functional areas need biotechnologists:
genetics, including medical genetics, genetic counseling, and genetic nursing
organ transplantation, reproduction, and regenerative medicine
public health and safety, which includes projects ranging from vaccine development to wastewater treatment by bacterial colonies
gene testing and genetic therapy

Agriculture

Under the broad heading of agriculture, the following functional areas rely on the application of biotechnology and consequently are the areas where biotech jobs are to be found:
development of genetically modified variations of plants and seeds
development of biological pesticides and nutrition
identification and protection of endangered species, including artificial breeding
verification and authentication of costly food products
Bioinformatics
Under this broad heading come:
computational biology
supercomputing
statistical and actuarial functions
data analysis, data transfer, database creation, and other data-related functions

Law

With the rise in the use of biotechnology, openings for biotechnologists have also opened up in the legal field. Openings are principally located in the following functional areas:
patent specialties and litigation
academia
ethical, social, and legal issues
forensic sciences, including gene testing for identification purposes

Guided Missile Development and Space Technology

Biotechnologists are required in organizations engaged in manufacturing guided missiles and space vehicles. Functional areas include:
creation of closed artificial environments
creation of life-supporting equipment and systems
research into the effects of space on biological systems
cybernetics

Engineering

There are many opportunities for biotechnologists in the field of engineering. Biotechnologists working in this area may be involved in:
designing bioprocessing containers and equipment
creating new energy sources such as biofuels
biomedical engineering

Education

Obviously a need for biotechnologists who can teach will always exist. Types of opportunities available in biotechnological education reflect the needs of universities and traditional academic structure.
Besides the above fields, there are myriad other divisions of applied biotechnology, including life-science research, anthropology, history, military, bio-science communication, and chemical manufacturing.

Biotech Job Designations

Biotech job designations are as varied as the fields in which biotechnology finds application. Though designations can reflect the imagination of the employer, some standard, industry-recognized designations that are related to biotechnology or the application of biotechnical knowledge are veterinary assistant, veterinarian, technician, technologist, chemist, pharmacologist, laboratory technician, chemical technician, engineer, computer system analyst, health service worker, physician, biological scientist, biotechnologist, and agricultural technician. One's designation depends on the organization, industry, and sector in which he or she works, and job designations can be superficially misleading.

Biotechnology – Its Latest Trends And Techniques

One of the fastest growing research areas in the world is Biotechnology as we know it. The basic idea behind biotechnology is using living things to create products rather than the other way around. We often times see that the living organisms are nothing more than parts of DNA structure or code which will help the researcher to develop the idea that he or she has working. The organisms do what the research does not have the power to do, hence their small size. The organisms are used to perform the tasks that are impossible for humans and can only be accomplished by the tiny particles that are working inside everything we see and touch on a daily basis.

The trends in biotechnology are inviting to a good many areas of the world. The industrial sector is extremely interested in biotechnology as they need new ways to develop products without the use of humans. This is generally because the process that is used to make the products can be overtly dangerous to people and the job needs to be performed by something that will not be harmed. This is where biotechnology fits into the process. The particles that are used will set to work doing the only task they know how. This in turn helps the company as they have developed the way to make sure that none of their employees were harmed and the job was done correctly without the intervention of humans to the methods. This is popularly shown with the new one way reactor that is being installed with many of the larger industry areas. Rather than the power having to move back and fourth it comes out and stays out while the reactor continues to make more. This would not be possible if it were not for the biotechnology research that has been done in this area.

The other most important area that biotechnology is present in is the medical or red sector. Using the techniques that biotechnology employs researchers believe that they are very close to having a system that will diagnose and attack tumors in the body without surgery. This would all be done by way of an injection that would contain the biotechnology particles and organisms that are specifically made to attack and diagnose the tumor as it is found in the body. This is very good news for the many cancer patients of the world. When you operate on a cancer patient you run the risk of the disease spreading or missing some of the cancerous material that is contained therein. This will be completely unnecessary if the use of biotechnology reaches a point where it will do the job that it is made to do.

Biotechnology is changing the way that the world is created around us and is working to help cure some of the most horrible diseases that are currently known to man.

Wednesday, July 23, 2008

Biotechnology Certificate and Training Programs

A cursory look at jobs that are being offered in biotechnology, bioscience and life science, by companies, organizations and institutions, demonstrates the wide range of job titles and jobs offerings available to job seekers. True, many of these entities are conducting cutting-edge research and development, but it is also true that like other industries they require support from employees who have skills and expertise in other fields that enable them to conduct their overall operations.

Biotechnology companies (and such allied industries as pharmaceuticals, health care, bioinformatics, agriculture and engineering), organizations and educational institutions require employees with diverse expertise from a variety of fields for efficient, productive operation. Employees are required in such fields as:

Accounting and finance, administration, management, Human Resources, technical writing, marketing, Quality Assurance, medical sales, IT, Multimedia, Graphic Design, and law

The growing field of biotechnology is also creating career opportunities that do not require advanced degrees. These jobs titles include:

Assay analyst, media prep technician, glasshouse assistant, glass washer, instrument calibration technician, documentation specialist, lab technician, library asssistant, technical services representative, buyer, and medical and paraprofessional support

Certificate and Training Programs

Many community and junior colleges, as well as some colleges and universities, are offering short-term biotechnology training and certificate programs, A. A. and B. A. degrees. Some universities are also offering graduate certification programs. The following include some of the institutions that are offering training and certificate programs:

California State University, Hayward (CSUH) --Biotechnology Certificate Program (BCP) -- The Biotechnology Certificate Program (BCP) was established at CSUH in 1986 to meet the personnel requirements of the rapidly expanding Bay Area biotechnology industry. The program was among the first in California to offer an integrated series of courses in the molecular life sciences leading to a certificate. CSUH is presenting two new programs of study in Bioinformatics and Regulatory Affairs. The Bioinformatics program is offered in the evening and the Regulatory Affairs program is completely on-line and is offered in association with San Diego State University.

California State University, Los Angeles-- Biotechnology (Post-baccalaureate) Certificate Program-- This post-baccalaureate certificate program provides intensive theoretical and laboratory training in the techniques and application of genetic engineering and related technologies. It is meant for students who have a bachelor's degree or equivalent in the biological or biochemical sciences but who have little or no experience in genetic engineering.

Columbia University Teachers College -- Certificate in Health Disparities Reduction-- This online or in-person certificate program in Health Disparities Reduction is offered jointly through the Department of Behavioral Studies Program in Health Education and the Center for Educational Outreach and Innovation at Teachers College, Columbia University, This program is for professionals with varied backgrounds who share an interest in being exposed to knowledge, attitudes/beliefs, and skills seen as central to the task of working to reduce disparities in health. Building upon their area-specific or pre-existing professional and academic preparation; those admitted will hold a minimum of a BA or BS degree. These professionals include but are not limited to allied healthcare professionals, social workers, health and related counseling professionals, researchers, teachers, doctors and health and school administrators working in an urban setting in particular, as well as others nationwide who are seeking distance learning opportunities.

Indiana University School of Medicine--The Graduate Certificate in Biotechnology is designed to train technicians for working in health-related industrial research laboratories, including those at the IU School of Medicine. Students also have access to IUSM core facilities in gene expression analysis, genotyping, protein expression, animal experimentation, proteomics, imaging and cell analysis research.

Ivy Tech Community College-Bloomington-- Biotechnology Program-- Ivy Tech Community College's Biotechnology degree program is designed to provide an educational opportunity to students who want to take career paths in Biotechnology as entry-level technicians.

Ohio State Agricultural Technical Institute, OH--Ohio State ATI has a broad range of programs in agriculture: horticulture, animal sciences, crop sciences, environmental sciences, and engineering technologies. They have the largest number of 2 year agricultural graduates in the nation.

Seattle Central Community College -- Biotechnology Training Program-- The Biotechnology Training Program prepares students for entry-level employment as biotechnicians and is approved by the college's industry-based Biotechnology Advisory Committee and the State of Washington. Classes in the program include cell biology, microbiology, genetics, immunology, chemistry, computer science applications, technical writing, applied mathematics, and hands-on training in biotechnology laboratory techniques and media and solution preparation.

University of California, San Diego--UCSD Extension--Offers Professional & Specialized Certificates in Biotechnology--San Diego's biotechnology, pharmaceutical and marine industries are important growth sectors in the California economy. UCSD Extension offers a broad array of courses and certificate programs to meet the continuing education needs of the life sciences community, support high-level skills development for industry professionals and career transition for those interested in entering the biotechnology field.

University of California, Irvine--The Medical Product Development Certificate Program is designed for engineers, scientists, regulatory professionals, managers, physicians, and marketing and sales professionals involved in the medical product industry (degreed professionals or those with an associate degree). The Clinical Laboratory Science/Medical Technology (CLS/MT) Training Program is a full-time, one-year educational program that leads to a career in diagnostic laboratory medicine. UC Irvine Extension's program is designed to fill the growing need for professional learning that ensures designing and implementing clinical trials for success. The Medical Product Development program is designed to meet the need for comprehensive professional learning in the successful design, development and delivery of medical devices, pharmaceuticals, and other biomedical products.

University of Hawaii Community Colleges, Kapi'olani Community College-- Programs of Study include Medical Assisiting, Medical Laboratory Technician, Occupational Therapy Assistant, Pharmacy Technician, Radiologic Technology, Physical Therapy Assistant, and Respiratory Care Technician. The Nursing program offerings include Associate Degree in Nursing (ADN) Licensed Practical Nurse to Registered Nurse Transition Program.

San Diego State University Department of Biology: Certificate in Biotechnology-- San Diego State's biotechnology training program is designed to introduce undergraduate, postbaccalaureate, and postdoctoral students and technicians to state-of-the-art techniques used in molecular biological research laboratories as well as to qualify certificate recipients for employment in various sectors of the biotechnological arena.

University of California, Santa Cruz -- Certificate Program in Biotechnology, Applied and Natural Sciences Department-- UCSC Extension's highly regarded Biotechnology Certificate Program was developed to meet the industry's need for professionals who are knowledgeable about core principles and up-to-date on the latest technologies. Whether you are a scientist or a motivated professional from another discipline (IT, engineering, business, legal, financial, project management, and regulatory), this program is designed to help you to develop the solid scientific foundation and industry savvy needed to advance your career in the biopharmaceutical arena.
Certificate Contact: Applied and Natural Sciences Department, (408) 861-3860, or e-mail program@ucsc-extension.edu.

University of Rhode Island Certificate Programs-- Biotechnology Training Initiative Courses and Seminars-- Short courses and seminars ranging from half day to four full days are offered in various areas of operations and management of biotechnology, biomanufacturing, and clinical trials as well as basic areas of related research. Courses vary each semester and have included offerings in Tangential Flow Filtration (lecture and laboratory workshops); Environmental Health & Safety Challenges in Biotechnology and Emerging Industries; Genomics and Proteomics; Tools of Biotechnology; Survey of Systems Biology; and various Good Practices Courses such as Good Clinical Practice, Investigator Clinical Practice Training Program course, SOP Writing Skills (Basic and Improve), and Technical Writing.

University of Virginia, Biotechnology Associate Degree Program-- PVCC offers a two- year associate degree in biotechnology. This program provides PVCC students with the education and training needed to perform selected activities in a research laboratory. By successfully completing this biotechnology curriculum, students will develop the skills necessary to be competitive for laboratory specialist positions at the University of Virginia and for other lab research positions at biotech companies. This program was developed in response to a demonstrated need for additional laboratory specialists at UVA.

Workforce Alliance Biotechnology Training Grant -- The regional workforce investment board for Palm Beach County, Florida has developed a Biotech career ladder with course curriculum for certificate programs and plans to continue the development of a BS to MS program in Molecular Biology and Biotechnology based on coursework in advanced lab techniques. The program is designed to create Biotech career opportunities for participants living in the Treasure Coast.

Online Training and Certificate Programs

Such websites as California Virtual Campus (http://www.cvc.edu/) are also offering training and certifcate programs. The California Virtual Campus site is designed for those who want to further their educational objectives by linking to online courses and other services offered by the Golden State's colleges and universities. Many colleges and universities in other states are also offering Distance and Online E-Learning Certificate and Training Programs.

Monday, July 21, 2008

Background Requirements For Career In Biotechnology

If you're seeking a career in biotechnology, one thing is for certain ... the more education you have, the higher up you can go. The fact is, no matter where you wind up working, you will be surrounded by people with Ph.D.'s and medical degrees. It is highly unlikely that an individual without an advanced degree such as these will get to the top of the corporate chain.

Therefore a bachelor's degree in the life sciences is a bare minimum. After that, it is recommended that you pursue an advanced degree; whether it be a master's degree or higher. Common degrees include; molecular biology, cell physiology, biochemistry, genetics and the like.

You should plan to take as many labs in college as possible as these will provide you with hands-on experience. Teaching as a student-teacher is also a wise move, as is becoming a part of a research project. It is possible to co-author a quality research paper before you ever even graduate with a bachelor's degree.


Biotechnologists frequently gain employment for biotech corporations. Over the last two decades, thousands of biotech corporations have sprung up around the globe. From start-ups to companies the size of Amgen, the choices range from pay to research to prestige.

Employment in the biotech industry may also be sought in academic institutes; such as universities and non-profit organizations. These typically pay less than biotech corporations, but may have more opportunities for independent research.

As a biotechnologist, you will spend most of your work hours in a laboratory. The work can be tedious and requires patience, but many truly enjoy working with their hands. You will design and carry out experiments and will need to keep good records.

The best biotechnologists enjoy innovation and the spirit of helping to advance society. If you choose biotechnology as a career, you can expect to be right on the cutting edge of technology.
Author: John Daye

Sunday, July 6, 2008

How To Get A Perfect Biotechnology Job

The euphoria of graduation day has worn off. You have done it - finished up that degree, made your family proud, and now it is time to strike out on your own. Your love of the field led you to seek and earn a degree in biotechnology, but how do you go about finding a job in such a field? It isn't as hard as you might think. You can find a job in biotechnology, or any field, with a little bit of dedication and prep work.

Biotechnology - or the use of technology to modify organic (living) material - is a vast field that has been around for years. While there are several subcategories of the field, the main ones are agriculture, industry, medicine, and bioinformatics. The vastness of the field works in your favor, as there are many options for employment. You could end up working in a brewery or winery to make that perfect drink, or working in the field to minimize the damage an oil spill or other chemical spill might have on wildlife, or even working in a lab on pest control, genetics, or pharmaceuticals. All of it is biotechnology.

The vast array of options aside, how exactly do you go about securing that all-important job? In addition to a biology or biotech degree, you will need a strong resume. Post it to every online job bank you can. Really good ones for biotech jobs are www.Biospace.com, www.cleanroomjobs.net and www.Biotechnologyjobs.com. Posting your resume allows employers to find you. When they call, the initial screening is already complete, and you'll know you passed.

Search the online job bank databases as well. Don't just stick to popular sites like Monster, CareerBuilder, and HotJobs. Try looking at databases dedicated to the biotech job scene. In addition to the above two, check out www.ihirebiotechnology.com and www.sciencejobs.com. Many universities offer free job placement services and career counseling - take advantage of that while you can. They may have connections or knowledge of listings for entry level jobs that are not posted elsewhere.

Another approach to landing that job is to attend job fairs hosted by companies in the biotechnology industry. You can find out about these by reading newspaper classifieds, visiting the human resources pages of the companies you are interested in, and by checking announcements posted in job forums. Make your social networking time pay off!

Lastly, don't be afraid to use word of mouth when it comes to successful job searching. Sometimes, the adage, "It's not what you know, its who you know" proves true. Ask friends, family, or someone "in the know" if they are aware of any jobs that would be right for you. Sometimes, your best tools for job searching are your mouth and ears. Use them wisely.

As vast as the field of biotechnology is, you are bound to find at least an entry level position in a reasonable amount of time. With patience and persistence, the perfect biotechnology job will come your way. Use the resources that are available to you, and watch your career take off.

Wednesday, July 2, 2008

Biotechnology Timeline: Important Events And Discoveries In Biotechnology

977:

The Age of biotechnology arrives with “somatostatin” - a human growth hormone-releasing inhibitory factor, the first human protein manufactured in bacteria by Genentech, Inc. A synthetic, recombinant gene was used to clone a protein for the first time.

1978:

Genentech, Inc. and The City of Hope National Medical Center announce the successful laboratory production of human insulin using recombinant DNA technology. Hutchinson and Edgell show it is possible to introduce specific mutations at specific sites in a DNA molecule.

1979:

Sir Walter Bodmer suggests a way of using DNA technology to find gene markers to show up specific genetic diseases and their carriers. John Baxter reports cloning the gene for human growth hormone.

1980:

The prokaryote model, E. coli, is used to produce insulin and other medicine, in human form. Researchers successfully introduce a human gene - one that codes for the protein interferon- into a bacterium. The U.S. patent for gene cloning is awarded to Cohen and Boyer.

1981:

Scientists at Ohio University produce the first transgenic animals by transferring genes from other animals into mice. The first gene-synthesizing machines are developed. Chinese scientists successfully clone a golden carp fish.

1982:

Genentech, Inc. receives approval from the Food and Drug Administration to market genetically engineered human insulin. Applied Biosystems, Inc. introduces the first commercial gas phase protein sequencer.

1983:

The polymerase chain reaction is invented by Kary B Mullis. The first artificial chromosome is synthesized, and the first genetic markers for specific inherited diseases are found.

1984:

Chiron Corp. announces the first cloning and sequencing of the entire human immunodeficiency virus (HIV) genome. Alec Jeffreys introduces technique for DNA fingerprinting to identify individuals. The first genetically engineered vaccine is developed.

1985:

Cetus Corporation's develops GeneAmp polymerase chain reaction (PCR) technology, which could generate billions of copies of a targeted gene sequence in only hours. Scientists find a gene marker for cystic fibrosis on chromosome number 7.

1986:

The first genetically engineered human vaccine - Chiron's Recombivax HB - is approved for the prevention of hepatitis B. A regiment of scientists and technicians at Caltech and Applied Biosystems, Inc. invented the automated DNA fluorescence sequencer.

1987:

The first outdoor tests on a genetically engineered bacterium are allowed. It inhibits frost formation on plants. Genentech's tissue plasminogen activator (tPA), sold as Activase, is approved as a treatment for heart attacks.

1988:

Harvard molecular geneticists Philip Leder and Timothy Stewart awarded the first patent for a genetically altered animal, a mouse that is highly susceptible to breast cancer

1989:

UC Davis scientists develop a recombinant vaccine against the deadly rinderpest virus. The human genome project is set up, a collaboration between scientists from countries around the world to work out the whole of the human genetic code.

1990:

The first gene therapy takes place, on a four-year-old girl with an immune-system disorder called ADA deficiency. The human genome project is formally launched.

1991:

Mary-Claire King, of the University of California, Berkeley, finds evidence that a gene on chromosome 17 causes the inherited form of breast cancer and also increases the risk of ovarian cancer. Tracey the first transgenic sheep is born.

1992:

The first liver xenotransplant from one type of animal to another is carried out successfully. Chiron's Proleukin is approved for the treatment of renal cell cancer.

1993:

The FDA declares that genetically engineered foods are "not inherently dangerous" and do not require special regulation. Chiron's Betaseron is approved as the first treatment for multiple sclerosis in 20 years.

1994:

The first genetically engineered food product, the Flavr Savr tomato, gained FDA approval. The first breast cancer gene is discovered. Genentech's Nutropin is approved for the treatment of growth hormone deficiency.

1995:

Researchers at Duke University Medical Center transplanted hearts from genetically altered pigs into baboons, proving that cross-species operations are possible. The bacterium Haemophilus influenzae is the first living organism in the world to have its entire genome sequenced.

1996:

Biogen's Avonex is approved for the treatment of multiple sclerosis. The discovery of a gene associated with Parkinson's disease provides an important new avenue of research into the cause and potential treatment of the debilitating neurological ailment.

1997:

Researchers at Scotland's Roslin Institute report that they have cloned a sheep--named Dolly--from the cell of an adult ewe. The FDA approves Rituxan, the first antibody-based therapy for cancer.

1998:

The first complete animal genome the C.elegans worm is sequenced. James Thomson at Wisconsin and John Gearhart in Baltimore each develop a technique for culturing embryonic stem cells.

1999:

A new medical diagnostic test will for the first time allow quick identification of BSE/CJD a rare but devastating form of neurologic disease transmitted from cattle to humans.

2000:

"Golden Rice," modified to make vitamin A. Cloned pigs are born for the first time in work done by Alan Coleman and his team at PPL, the Edinburgh-based company responsible for Dolly the sheep.

2001:

The sequence of the human genome is published in Science and Nature, making it possible for researchers all over the world to begin developing genetically based treatments for disease.

2002:

Researchers sequence the DNA of rice, and is the first crop to have its genome decoded.

2003:

The sequencing of the human genome is completed.